Chapter category: Pharmacogenomics

Pharmacogenetics of Cytochrome P450 in Hispanic Populations

This chapter appears in the following book:

Pharmacogenomics
in Admixed Populations

Edited by: Guilherme Suarez-Kurtz
ISBN: 978-1-58706-311-4
» Get more information about this book at landesbioscience.com «

Chapter authors:
Pedro Dorado, Guilherme Suarez-Kurtz and Adrian LLerena

[+] view image

The present review focuses on the pharmacogenetics of the cytochrome P450 (CYP) enzymes in Hispanic populations, comprising the people living in Spanish speaking countries of the Americas as well as those categorized as Hispanics in the United States. We acknowledge the diversity of these peoples by their country of origin or residence, culture, as well as genetic composition, the latter resulting from centuries of inter-ethnic crosses between Amerindians, Europeans and Africans. This diversity is reflected in the frequency distribution of polymorphisms at the CYP genes that encode the main CYP enzymes involved in the biotransformation of xenobiotics, namely CYP1A1, CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4 and CYP3A5. Our review of the literature disclosed data for all these CYPs only in Mexicans or Mexican-Americans. For other populations, including extant Amerindian groups, scattered information was recovered on individual CYPs. For several Latin American countries, no information could be retrieved on any of these enzymes or, indeed other pharmacogenetic targets. With the purpose of fulfilling this information gap and to promote collaborative pharmacogenetic/genomic research in Spanish- and Portuguese-speaking peoples in the Americas and the Iberian peninsula, a network—the Iberian American Network of Pharmacogenetics and Pharmacogenomics—was recently created. This initiative represents a promising step towards the inclusion of Latin American populations among those who will benefit from the implementation of pharmacogenetic principles and tools in drug therapy.

Pedro Dorado

Guilherme Suarez-Kurtz

Adrian LLerena

» Access chapter for $19

Additional chapters from this book:

Pharmacogenetics, Ethnic Differences in Drug Response and Drug Regulation

Rashmi R. Shah

The two key components in the pathway between the administration of a drug and the clinical response it elicits are the dose-concentration (pharmacokinetic) and/or concentration-response (pharma...

Admixture in North America

Esteban Parra

The history of North America has been marked by the encounter of populations from different continents. The discovery of the New World began a period defined by human migrations at a much larger...

Pharmacogenetic Studies in the Brazilian Population

Guilherme Suarez-Kurtz and Sergio D.J. Pena

By virtue of being the product of the genetic admixture of three ancestral roots: Europeans, Africans and Amerindians, the Brazilian population displays very high levels of genomic diversity an...

Pharmacogenetics of Cytochrome P450s in African Populations: Clinical and Molecular Evolutionary Implications

Eleni Aklillu, Collet Dandara, Leif Bertilsson and Collen Masimirembwa

Though the pharmacogenetics of drug metabolism had its origins in the 1960s, it is only during the past 10 years that it begun to have clinical impact and pharmaceutical industry recognition. The dela...

Pharmacogenetics and Ethnicity: An Asian Perspective

Su Pin Choo, Suman Lal and Balram Chowbay

The improved understanding and merging of the areas of genomic research and thera- peutics have resulted in a rapid acceleration in the area of pharmacogenomics. The clinical implications of this...

The Evolution and Structure of Human Genetic Diversity

Sergio D.J. Pena

The conceptual development and the praxis of pharmacogenetics and pharmacogenomics will depend on a solid understanding of the evolution and structure of human genomic diversity. In this review ...

Pharmacogenomics in the Indian Population

M. Ravindra Kumar and C. Adithan

India is one of the most diverse countries in the world. There are more than 200 languages spoken in India and 22 of them are considered official language. The population is segregated into endo...

Pharmacogenetics of Cytochrome P450 in Hispanic Populations

Pedro Dorado, Guilherme Suarez-Kurtz and Adrian LLerena

The present review focuses on the pharmacogenetics of the cytochrome P450 (CYP) enzymes in Hispanic populations, comprising the people living in Spanish speaking countries of the Americas as wel...

Human Genomic Variation Studies and Pharmacogenomics Are Critical for Global Health

Beatrice Seguin, Samina Essajee, Gerardo Jimenez-Sanchez, Peter A. Singer and Abdallah S. Daar

Many people in the world still lack access to essential medicines. The World Health Organization (WHO) has attempted to address this inequity by creating the essential medicines list (See http://www.w...

Pharmacogenetics in Chinese Population

Hong-Hao Zhou and Wei Zhang

Genetic variations of drug-metabolizing enzymes, receptors and transporters have been recognized as major causes of the interindividual variability in drug responses. As a result of the genotype...

Pharmacogenetics in the African American Population

Howard McLeod

There is great heterogeneity in the way humans respond to medications, often requiring empirical strategies to define the appropriate drug therapy for each patient. Genetic polymorphisms in drug...

Pharmacogenetics in Admixed Polynesian Populations

Rod A. Lea and Geoffrey K. Chambers

Collectively, the islands of the remote Pacific Ocean form the last geographic region on earth to be colonised by humans. The region is known as Polynesia and is defined by a triangular boundary joini...

Controlling the Effects of Population Stratification by Admixture in Pharmacogenetics

Eduardo Tarazona-Santos, Sara Raimondi and Silvia Fuselli

Admixture is a common type of gene flow in human populations, and occurs when individuals from two or more parental populations that have been isolated for several generations, form a new hybrid...

Synopsis and Perspectives

Guilherme Suarez-Kurtz

“P harmacogenetics deals with pharmacological responses and their modification by hereditary influences”. This definition, offered by Werner Kalow in the first book dedicated to pharmacogenetics...

Chapter category: Pharmacogenomics

Pharmacogenetics of Cytochrome P450 in Hispanic Populations

Additional chapters from this book:

SIGN IN